ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2025
Design and evaluation of light-responsive ruthenium complexes for neurotransmitter release: synthesis, characterization, DFT and gene regulation studies.
Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ru-Based Photocaged Kinase Inhibitors Operative under Deep-Red Light Irradiation.Journal of the American Chemical Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Neurotransmitters are critical biomolecules involved in the mediation of synaptic transmission and the control of many neurophysiological processes. Their therapeutic potential, however, is usually limited by fast degradation, off-target action, and absence of spatial targeting. Photoactivated chemotherapy (PACT) offers a potential solution for spatially and temporally controlled delivery of bioactive molecules. In this paper, neurotransmitters were encapsulated in light-sensitive ruthenium (II) polypyridyl caged complexes, which would be inert in the dark and release upon irradiation with 465 nm blue light through photolysis. The complexes were prepared and thoroughly characterized by UV-VIS spectroscopy, FTIR, ESI-MS, NMR, CHNS elemental analysis, and ICP-MS, establishing coordination and structural integrity. Photorelease of neurotransmitters was verified by time-resolved UV-VIS and mass spectrometric investigations. To assess the biological relevance of light-induced release, gene expression analysis was conducted, demonstrating upregulation of the important neuronal markers after irradiation. The findings prove the efficiency of ruthenium-based cages in light-regulated neurotransmitter delivery and justify their possible application in neurotherapeutic PACT platforms.
Indexed as
Identifiers
40960728What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.